Meet Dr. Trudy K. Ramjattan

Trudy K. Ramjattan, M.D.

Trudy K. Ramjattan, M.D. – Ophthalmology

Board Certified – American Board of Ophthalmology

Dr. Ramjattan graduated at the top of her class in Biomedical Engineering at the University of Miami and received her medical degree from the University of Florida. She served her internship at Carilion Roanoke Memorial Hospital in Virginia and completed her residency with the University of Florida Department of Ophthalmology which included training at Shands Hospital at the University of Florida, Malcolm Randall VA Medical Center, Lake City VA Medical Center and Naval Air Station in Jacksonville, Florida.

In 2008, she was awarded third place in the National Bloomberg Memorial Competition for Cataract/Implant Surgery by the American Board of Eye Surgery. She has also enjoyed participating in medical mission trips to Nicaragua and the Dominican Republic and volunteering for The Alachua County Medical Society We Care Physician Referral Network.  [visit the ACMS website]

Dr. Ramjattan is a Diplomate of the American Board of Ophthalmology and is a member of the American Academy of Ophthalmology and The American Society of Cataract and Refractive Surgeons. She is on staff at Pasadena Surgery Center.

• University of Florida Department of Ophthalmology – Residency with training at the following institutions:
    - Shands Hospital at the University of Florida
    - Malcolm Randall VA Medical Center
    - Lake City VA Medical Center
    - Naval Air Station in Jacksonville, Florida (Refractive Surgery)
• Carilion Roanoke Memorial Hospital, Roanoke,Virginia (Internship – Transitional year)
• University of Florida College of Medicine (Medical Doctorate)
• University of Miami, Florida (Bachelor of Science, Biomedical Engineering – Cum Laude)

Research and Development
Sub-Investigator: Phase III, Randomized, Double-Masked, Active-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension -Spectrum 4 Study. Sponsored by Santen. DE-117 Protocol: 011710IN (#1011541).

Sub-Investigator: Phase II, randomized, double-masked study to evaluate the efficacy and tolerability of topical ocular delivery of fixed-dosed combinations of Trabodenoson and Latanoprost in subjects with Ocular Hypertension or Primary Open-Angle Glaucoma. Sponsored by lnotek. Protocol: IPC-02-2015.

Sub-Investigator: Phase III, Double-masked, Randomized, Multi-center, Active-controlled, Parallel, 12-month Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-13324 Ophthalmic Solution, 0.02% q.d. and b.i.d. Compared to Timolol Maleate Ophthalmic Solution, 0.5% b.i.d. in Patients With Elevated lntraocular Pressure. Sponsored by Aerie. Protocol: AR-13324-CS302 (Rocket 2).

Sub-Investigator: Phase I/II Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics (Efficacy) of Chronic Twice-Daily Topical Monocular Application of INO-8875 Ophthalmic Formulation in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma. Sponsored by lnotek. Protocol: IPC-10-2009.

Sub-Investigator: Phase III, Randomized, Active Comparator-Controlled, Twelve Week, Double-Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients With Open-Angle Glaucoma and Ocular Hypertension. Sponsored by Merck.

Ophthalmic Examiner: A Randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study with a 26-Week Long-Term Safety Extension, of High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Formulation Compared With Formoterol and High-Dose Inhaled Mometasone Furoate Monotherapy in Subjects With Moderate to Severe. COPD. SPRI PO4229/PO0430.

Ophthalmic Examiner: A One year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients with Major Depressive Disorder. Protocol: CLDA-07-DP-04.

Ramjattan, T., Tuli S. Poster: Infectious Keratitis in North Florida: Epidemiology, Treatment, and Outcomes. ARVO, Fort Lauderdale, FL.

Migration of Glaucoma Drainage Device Extender Into the Anterior Chamber After Trauma. Case Report. Journal of Glaucoma. 15(6):559-561, December 2006.

Investigation of the Folding of Mutant Proteins Involved in Retinitis Pigmentosa – under the direction of Shalesh Kaushal, M.D., Ph.D. Department of Ophthalmology, University of Florida College of Medicine.

Honors and Awards
• Bloomberg Memorial Video Competition for Cataract Implant Surgery – Evaluation of Surgical Skills established by the American Board of Eye Surgery
• H.M. Hill Letter of Appreciation
• Paul Heustis Ophthalmology Scholarship
• The Samuel S. Lee Award for Outstanding Academic Excellence – Awarded to the Student graduating at the top of the class of the College of Engineering
• The Jacob Kline Founders Award in Biomedical Engineering – Awarded for Outstanding Senior Undergraduate
• The Norman G. Einspruch Scholar – Awarded to the top Junior student of the College of Engineering